Clinical Trial Update: Interferon Alfa and Thalidomide in Treating Patients With Soft Tissue Sarcoma or Bone Sarcoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating interferon alfa in combination with thalidomide for soft tissue sarcoma or bone sarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Sarcoma
• Soft Tissue Sarcoma

Drugs mentioned

• Interferon Alfa (interferon alfa)
• Thalidomide (thalidomide)

Snippet

Sponsor: Herbert Irving Comprehensive Cancer Center | Conditions: Sarcoma | Phase 2 | Status: UNKNOWN